Barclays PLC Volitionrx LTD Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.96 - $3.05 $53,264 - $82,886	-27,176 Reduced 92.0%	2,363 $5,000
Q4 2021 Feb 14, 2022	BUY	$3.02 - $4.13 $79,664 - $108,945	26,379 Added 834.78%	29,539 $93,000
Q3 2021 Nov 09, 2021	SELL	$2.98 - $3.48 $15,880 - $18,544	-5,329 Reduced 62.78%	3,160 $10,000
Q2 2021 Aug 13, 2021	SELL	$3.01 - $3.78 $64,651 - $81,190	-21,479 Reduced 71.67%	8,489 $28,000
Q1 2021 May 13, 2021	BUY	$3.33 - $6.5 $50,419 - $98,416	15,141 Added 102.12%	29,968 $113,000
Q4 2020 Feb 11, 2021	SELL	$2.88 - $4.33 $10,180 - $15,306	-3,535 Reduced 19.25%	14,827 $57,000
Q3 2020 Nov 12, 2020	SELL	$2.94 - $4.05 $1,669 - $2,300	-568 Reduced 3.0%	18,362 $59,000
Q2 2020 Aug 12, 2020	BUY	$2.89 - $4.32 $54,707 - $81,777	18,930 New	18,930 $73,000
Q4 2019 Feb 10, 2020	SELL	$4.28 - $5.95 $856 - $1,190	-200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.97 - $6.42 $594 - $1,284	200 New	200 $1,000
Q2 2018 Aug 14, 2018	SELL	$1.88 - $2.41 $1 - $2	-1 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.29 - $3.95 $2 - $3	1 New	1 $0

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $38.4M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.